Current Report Filing (8-k)
February 05 2020 - 1:52PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
February 4, 2020
OZOP SURGICAL CORP.
(Exact name of registrant as specified in
its charter)
Nevada
|
000-55976
|
35-2540672
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(I.R.S. Employer Identification Number)
|
319 Clematis Street Suite 714 West Palm Beach
FL 33401
(Address of principal executive offices, including
zip code)
(866) 286-1055
(Registrant’s telephone number, including
area code)
Not applicable.
(Former name or former address, if changed since
last report)
Check the appropriate box below if the Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
☐
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
☐
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☑
☐
|
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
|
|
Item 5.03
|
Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.
|
On February 4, 2020, the Company filed an Amended
and Restated Certificate of Designation with the State of Nevada of the Company’s Series C Preferred Stock (the “Preferred
Stock”). The voting rights associated with the Preferred Stock were amended whereby each share of Preferred Stock shall entitle
the holder thereof to have voting rights equal to two times the sum of all the number of shares of other classes of Company capital
stock eligible to vote on all matters submitted to a vote of the stockholders of the Company, divided by the number of shares of
Preferred Stock issued and outstanding at the time of voting.
The foregoing descriptions
of the rights and preferences of the Amended and Restated Certificate of Designation of the Series C Preferred Stock is qualified
in its entirety by the full text of the Amended and Restated Certificate of Designation, which is filed as Exhibit 3.1 to, and
incorporated by reference in, this report.
|
Item 9.01
|
Financial Statements and Exhibits.
|
The exhibit listed in the following Exhibit
Index is filed as part of this report:
Exhibit No.
|
|
Description
|
|
|
|
3.1
|
|
Amended
and Restated Certificate of Designation of Series C Preferred Stock.
|
|
|
|
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto
duly authorized.
Date: February 5, 2020
OZOP SURGICAL CORP.
By: /s/ Barry Hollander
Barry Hollander
Chief Financial Officer
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ozop Energy Solutions (PK) (USOTC:OZSC)
Historical Stock Chart
From Apr 2023 to Apr 2024